EUCLIDEAN CAPITAL LLC – ORIC Pharmaceuticals, Inc. Transaction History
EUCLIDEAN CAPITAL LLC portfolio value:
$2.39M
portfolio value
EUCLIDEAN CAPITAL LLC quarter portfolio value change:
-28.57%
quarter
ORIC Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -957K | $3.2 | 747.55K | |
| Q2 2022 | share | 0.00% | 0 shares | -643K | $4.48 | 747.55K | |
| Q1 2022 | share | 0.00% | 0 shares | -6.99M | $5.34 | 747.55K | |
| Q4 2021 | share | Decrease | -3.81% | -29.64K shares | -5.26M | $15.59 | 747.55K |
| Q3 2021 | share | Decrease | -22.03% | -219.54K shares | -1.38M | $20.91 | 777.19K |
| Q2 2021 | share | 0.00% | 0 shares | -6.78M | $17.69 | 996.73K | |
| Q1 2021 | share | Decrease | -28.83% | -403.70K shares | -22.98M | $24.5 | 996.73K |
| Q4 2020 | share | Increase | 0.00% | 1.40M shares | 47.40M | $33.85 | 1.40M |